Literature DB >> 9482391

A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion.

S Holme1, G Moroff, S Murphy.   

Abstract

BACKGROUND: There is no consensus regarding the use of specific in vitro tests for the assessment of the quality of platelet components. A literature review found that the platelet discoid shape as measured photometrically by the extent of shape change (ESC) and hypotonic shock response (HSR) correlated well with in vivo viability. The purpose of this study was to determine whether multiple research laboratories can perform the ESC and HSR assays in an accurate, reproducible manner, with acceptable sensitivity and comparable results. STUDY DESIGN AND METHODS: Eleven laboratories conducted five identical experiments, each with a different unit of platelet-rich plasma (PRP). For each experiment, 2 half-units of PRP were prepared and stored overnight: 1 half-unit at 20 to 24 degrees C in CPD (CPD-PRP) and the other at 1 to 6 degrees C with 2 mg per mL of EDTA (cold EDTA-PRP) added to produce spherical platelets with reduced HSR. Platelet suspensions having different proportions of the two PRPs were prepared and evaluated in duplicate by ESC and HSR assays, and morphologically scored by microscopy. One-way ANOVA and Duncan multiple-range tests were performed to determine significant differences in assay results for suspensions having different proportions of CPD-PRP.
RESULTS: Comparable ESC (mean range: 20-28% for CPD-PRP and 1-6% for cold EDTA-PRP) and HSR (mean range: 58-81% for CPD-PRP and 12-31% for cold EDTA-PRP) measurements were obtained by nine laboratories. Duplicate testing showed high reproducibility of ESR and HSR results /in all laboratories. A 25-percent difference in the proportion of CPD-PRP (indicative of a difference of approximately 25% in the proportions of discoid and spherical platelets) was detected with a sample size of five (p<0.05) for both the ESC and HSR assays. A high correlation was found for the ESC assay and morphology score (r = 0.93, n = 345).
CONCLUSION: Multiple laboratories were able to obtain comparable results with the ESC and HSR tests. They were able to show that the tests can be performed in an accurate, reproducible manner and with acceptable sensitivity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482391     DOI: 10.1046/j.1537-2995.1998.38198141495.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  22 in total

1.  Extended storage of platelet-rich plasma-prepared platelet concentrates in plasma or Plasmalyte.

Authors:  Sherrill J Slichter; Doug Bolgiano; Jill Corson; Mary Kay Jones; Todd Christoffel
Journal:  Transfusion       Date:  2010-10-04       Impact factor: 3.157

2.  Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system.

Authors:  Eva María Plaza; María Luisa Lozano; Isabel Sánchez Guiu; José Manuel Egea; Vicente Vicente; Laura Collantes De Terán; José Rivera
Journal:  Blood Transfus       Date:  2012-04-13       Impact factor: 3.443

3.  A signaling pathway contributing to platelet storage lesion development: targeting PI3-kinase-dependent Rap1 activation slows storage-induced platelet deterioration.

Authors:  Peter Schubert; Jonathan N Thon; Geraldine M Walsh; Cindy H I Chen; Edwin D Moore; Dana V Devine; Juergen Kast
Journal:  Transfusion       Date:  2009-05-18       Impact factor: 3.157

4.  In vitro evaluation of pathogen-inactivated buffy coat-derived platelet concentrates during storage: psoralen-based photochemical treatment step-by-step.

Authors:  Mélanie Abonnenc; Giona Sonego; Julie Kaiser-Guignard; David Crettaz; Michel Prudent; Jean-Daniel Tissot; Niels Lion
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

5.  Increase of plasma concentration to 10% improves a number of in vitro storage parameters of apheresis platelets suspended in a bicarbonate-containing additive solution and stored with a 24-hour interruption of agitation.

Authors:  Stephen J Wagner; Andrey Skripchenko; Cheryl A Hapip; Nadine Kaelber; Annette Turgeon
Journal:  Blood Transfus       Date:  2017-03-02       Impact factor: 3.443

6.  The Mirasol Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution.

Authors:  Håkon Reikvam; Susanne Marschner; Torunn Oveland Apelseth; Ray Goodrich; Tor Hervig
Journal:  Blood Transfus       Date:  2010-07       Impact factor: 3.443

7.  Effect of storage on levels of nitric oxide metabolites in platelet preparations.

Authors:  Ji Won Park; Barbora Piknova; James Kurtz; Shalini Seetharaman; Stephen J Wagner; Alan N Schechter
Journal:  Transfusion       Date:  2012-07-15       Impact factor: 3.157

8.  In vitro Quality of Platelets with Low Plasma Carryover Treated with Ultraviolet C Light for Pathogen Inactivation.

Authors:  Lacey Johnson; Ryan Hyland; Shereen Tan; Frank Tolksdorf; Chryslain Sumian; Axel Seltsam; Denese Marks
Journal:  Transfus Med Hemother       Date:  2015-11-05       Impact factor: 3.747

9.  Extended storage of buffy coat platelet concentrates in plasma or a platelet additive solution.

Authors:  Sherrill J Slichter; Doug Bolgiano; Jill Corson; Mary Kay Jones; Todd Christoffel; S Lawrence Bailey; Esther Pellham
Journal:  Transfusion       Date:  2014-03-28       Impact factor: 3.157

10.  Extended storage of autologous apheresis platelets in plasma.

Authors:  S J Slichter; D Bolgiano; J Corson; M K Jones; T Christoffel; E Pellham
Journal:  Vox Sang       Date:  2013-02-06       Impact factor: 2.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.